A noted serial device entrepreneur and two experienced industry executives have joined a public-private Planning Board tasked with spearheading reforms to the US medical device postmarket surveillance system.
The appointments of three industry veterans and one academic, announced Dec. 7, were targeted at "increasing the diverse range of stakeholders involved" in developing the National Medical Device Surveillance System, according to the Planning Board, which is administered by the Brookings Institution with participation by FDA and other government agencies. The board sought nominations to support its next two-year phase of development
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?